Stategies that increase the production of endogenous chemicals that are depleted in Alzheimer's Disease patients may be useful therapies for the treatment of Alzheimer's Disease.
Amines
Low levels of Polyamines is a possible biomarker for Alzheimer's Disease (and raising endogenous Polyamines levels may be beneficial fo ...